.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Bringing Oncology Biosimilars to Patients

EP. 1: Patient Awareness of Biosimilars and Loyalty to Branded Drugs

January 24th 2018

EP. 2: Patient Savings From Biosimilars

January 24th 2018

EP. 3: Barriers to Biosimilars for Oncology Patients

January 24th 2018

EP. 4: Biosimilars, Payers, and Formulary Changes

January 24th 2018

EP. 5: The Exceptions Process and its Effect on Patients

January 24th 2018

EP. 6: Patient Education on Coverage for Biologics and Biosimilars

January 24th 2018

EP. 7: Alternative Payment Models and Patient Care

January 24th 2018

EP. 8: The Cost of Biologics and Biosimilars

January 24th 2018

EP. 9: Rebates and Medicare Part D

January 24th 2018

EP. 10: CMS' Changes to Reimbursement for Biosimilars

January 24th 2018